Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 529

    2.

    A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes.

    Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K.

    Diabetes. 2003 Oct;52(10):2461-74.PMID: 14514628 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.

    Carpentier A, Mittelman SD, Bergman RN, Giacca A, Lewis GF.

    Diabetes. 2000 Mar;49(3):399-408.PMID: 10868961 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes.

    Boden G, Chen X.

    Diabetes. 1999 Mar;48(3):577-83.PMID: 10078559 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.

    Mason TM, Goh T, Tchipashvili V, Sandhu H, Gupta N, Lewis GF, Giacca A.

    Diabetes. 1999 Mar;48(3):524-30.PMID: 10078552 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Insulin secretion after short- and long-term low-grade free fatty acid infusion in men with increased risk of developing type 2 diabetes.

    Storgaard H, Jensen CB, Vaag AA, Vølund A, Madsbad S.

    Metabolism. 2003 Jul;52(7):885-94.PMID: 12870166 [PubMed - indexed for MEDLINE]Related articles

    7.

    Elevation of plasma fatty acids by ten-hour intralipid infusion has no effect on basal or glucose-stimulated insulin secretion in normal man.

    Amery CM, Round RA, Smith JM, Nattrass M.

    Metabolism. 2000 Apr;49(4):450-4.PMID: 10778867 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of an intravenous lipid challenge and free fatty acid elevation on in vivo insulin sensitivity in African American versus Caucasian adolescents.

    Burns SF, Kelsey SF, Arslanian SA.

    Diabetes Care. 2009 Feb;32(2):355-60. Epub 2008 Nov 18.PMID: 19017772 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of a 48-h fat infusion on insulin secretion and glucose utilization.

    Boden G, Chen X, Rosner J, Barton M.

    Diabetes. 1995 Oct;44(10):1239-42.PMID: 7556964 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of free fatty acids and glucose on splanchnic insulin dynamics.

    Hennes MM, Dua A, Kissebah AH.

    Diabetes. 1997 Jan;46(1):57-62.PMID: 8971082 [PubMed - indexed for MEDLINE]Related articles

    12.

    Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation.

    Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF.

    Am J Physiol. 1999 Jun;276(6 Pt 1):E1055-66.PMID: 10362618 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects.

    Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F.

    Diabetologia. 1995 Nov;38(11):1295-9.PMID: 8582538 [PubMed - indexed for MEDLINE]Related articles

    14.

    Young, low-birth-weight men are not more susceptible to the diabetogenic effects of a prolonged free fatty acid exposure than matched controls.

    Jensen CB, Storgaard H, Holst JJ, Dela F, Madsbad S, Vaag A.

    Metabolism. 2005 Oct;54(10):1398-406.PMID: 16154442 [PubMed - indexed for MEDLINE]Related articles

    15.

    The impact of acute elevation of non-esterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes.

    McLachlan KA, Alford FP.

    Clin Endocrinol (Oxf). 2005 Jan;62(1):79-84.PMID: 15638874 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.

    Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E.

    Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1775-81. Epub 2007 Feb 13.PMID: 17299078 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

    Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

    Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.

    Storgaard H, Jensen CB, Björnholm M, Song XM, Madsbad S, Zierath JR, Vaag AA.

    J Clin Endocrinol Metab. 2004 Mar;89(3):1301-11.PMID: 15001626 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.

    Lewis GF, Vranic M, Harley P, Giacca A.

    Diabetes. 1997 Jul;46(7):1111-9.PMID: 9200644 [PubMed - indexed for MEDLINE]Related articles

    20.

    Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans.

    Dobbins RL, Chester MW, Daniels MB, McGarry JD, Stein DT.

    Diabetes. 1998 Oct;47(10):1613-8.PMID: 9753300 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data